Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The mobile phase was methanol and 0.1% phosphoric acid (9:1), the flow rate was 0.8 ml/min, the injection volume was 10 l, and the column temperature was 30 C
Cysteine was found to enhance the effect of topically applied silver or zinc salts in preventing dental cavities
STORAGE Store below 25C (Air Conditioning)
multiple doses sustain IGF-1 above baseline for weeks
The April 2026 TGA alert regarding unapproved GLP-1 receptor agonists (including Retatrutide) reinforced the distinction between therapeutic use, which remains unapproved, and research-grade supply for laboratory purposes, which is legally distinct under Australian law
US$ 25.89
US$ 26.74
US$ 26.95
